Procter & Gamble announced on Thursday that its quarterly profits and revenue both exceeded analysts' expectations, mainly driven by growing demand for laundry detergent and home care products.
The company's stock price rose by more than 2% before the market opened.
The following are the data published by Procter & Gamble, compared with the survey expectations of analysts by the London Stock Exchange Group ( LSEG ):
- Earnings per share: $2.00 after adjustment, expected to be $1.88
- Revenue: $23.3 billion, expected to be $22.8 billion
P&G announced that in the first fiscal quarter of the 2027 fiscal year, the net profit attributable to the company was $4.73 billion, or $1.97 per share, which is lower than the $4.75 billion, or $1.95 per share, in the same period last year.
After deducting reorganization costs and other items, the company's earnings per share are $2.
Net sales increased by 4% to $23.3 billion.
P&G announces a 2.4% increase in quarterly sales, marking a strong start to the new fiscal year. Like many consumer goods companies, P&G has also seen a decline in demand for its products as consumers become more focused on value for money.
Company executives previously stated that consumers now use shampoo or laundry detergent until the very last drop, and large-packaged products are becoming increasingly popular. In fiscal year 2026, Procter & Gamble only achieved sales growth in one quarter.
Procter & Gamble's best-performing division is the Fabric and Home Care business, which includes brands such as Tide ( Tide ) and Febreze . Sales in this division increased by 4.3% this quarter.
The company's baby, women's and family care business, as well as its beauty business, all saw sales growth of over 2% this quarter.
P&G's personal care business saw a 0.4% decline in sales this quarter. This segment includes Gillette ( Gillette ) and Venus razors.
This quarter, the company's health care business was the weakest segment of the portfolio. Due to a decline in demand for oral care products (such as Crest toothpaste) and personal health care products (such as Pepto-Bismol), sales for this business fell by 2.9%.
In a statement, CEO Shailesh Jejurikar stated that the company expects to continue facing "geopolitical and economic challenges" in the future, but Procter & Gamble is on track to achieve its goals as planned.
For the fiscal year 2027, Procter & Gamble reaffirmed its core earnings per share forecast range of $6.89 to $7.11. The company currently expects annual sales growth of 2% to 4%, which is higher than the previous forecast of 1% to 3%. This adjustment reflects its acquisition of the vitamin company Thorne, which was completed on October 1st.
